After conducting the research cited above, we have concluded that there remains a lot of opportunity for solid returns at reasonable levels of risk in today's market environment. (fastgraphs.com)
Point blank: The ETF route may not be as exciting as owning individual biotech stocks, but it comes with a more reasonable level of risk and respectable growth prospects. (fool.com)
This may be one industry that provides high yields in today's environment, coupled with reasonable levels of risk. (fastgraphs.com)